LATEST NEWS AND MEDIA

Insights from Leading Medical Experts

September 20, 2024

 

ONTIVTM (Ondansetron Hydrochloride)

ONTIVTM (Ondansetron Hydrochloride) Injection has been introduced in Pakistan

Read More

July 15, 2024

 

Vory ® (Voriconazole)

Vory ® (Voriconazole) Tablet has been introduced in Pakistan

Read More

July 15, 2024

 

Arcenate TM (Artesunate)

Arcenate TM (Artesunate) Injection has been introduced in Pakistan

Read More

June 7, 2024

 

Alkeris ® (Aceclofenac)

Alkeris ®(Aceclofenac) Cream has been introduced in Pakistan

Read More

June 7, 2024

 

Grudiz ® (Letrozole)

Grudiz ® (Letrozole) Tablet has been introduced in Pakistan.

Read More

June 7, 2024

 

Cistarium ® (Cisatracurium)

Cistarium ® (Cisatracurium) Solution for injection has been introduced in Pakistan.

Read More

February 13, 2024

 

Itaglip ® Plus XR (Sitagliptin Phosphate + Metformin HCI)

Itaglip ® Plus XR (Sitagliptin Phosphate + Metformin HCI) Tablets has been introduced in Pakistan

Read More

January 12, 2024

 

ZIVALO ® (Zoledronic Acid)

ZIVALO ® (Zoledronic Acid) Infusion has been introduced in Pakistan

ZIVALO ® (Zoledronic Acid) 5mg/100ml injection in pack of 1’s.

Read More

January 12, 2024

 

VONOLIA (Vonoprazan Fumarate)

VONOLIA (Vonoprazan Fumarate) Tablets has been introduced in Pakistan

VONOLIA (Vonoprazan Fumarate) 10mg Tablets in pack of 14’s.

Read More

January 12, 2024

 

Ubrof ® (Ibuprofen)

Ubrof® (Ibuprofen) Injection has been introduced in Pakistan

Ubrof®(Ibuprofen) 800mg/8ml injection in pack of 1’s.

Read More

Disclaimer

SAMI Pharmaceuticals (Pvt) Ltd. are the sponsors of content of “INFECTIO MAGAZINE”, "INFECTIO SURGERY magazine" and "REHUMA FACTS" which is for educational purposes only. As sponsor, M/s SAMI Pharmaceuticals have no influence over or input on the scope, content or direction of the editorial material Any opinion, view or idea expressed in any article, review or any content contributed or published is the author’s own & does not reflect the views of SAMI Pharmaceuticals or its employees, officers, directors, professional advisors, affiliated and related entities, its partners, sponsors, advertisers or content providers (collectively referred to as “SAMI Pharmaceuticals Parties”). It should be noted that no SAMI Pharmaceuticals Parties shall be liable to any person or entity whomsoever for any loss, damage, injury, liability, claim or any other cause of action of any kind arising from the use, dissemination of or reliance on any materials and/or other contents provided in this Magazine.